While the pilot study successfully explored the efficacy of timolol eyedrops, further research is necessary to identify patients who would benefit the most from this treatment and an appropriate ...
Please provide your email address to receive an email when new articles are posted on . Timolol maleate 0.5% microdrops delivered with a volume-reducing adaptor provided noninferior IOP reduction ...
Credit: Getty Images. During the study, 50 migraine patients randomly received either topically applied timolol maleate ophthalmic solution, 0.5%, or placebo eyedrops. Timolol maleate ophthalmic ...
CHICAGO -- The Rho kinase inhibitor netarsudil (Rhopressa) demonstrated noninferiority to timolol ophthalmic solution for control of intraocular pressure (IOP), meeting the primary endpoint of a phase ...
Compr Ophthalmol Update. 2005;6(2):85-101. In summary, the aqueous suppressors timolol gel once daily and brinzolamide are recommended first-line glaucoma agents often used together, with timolol gel ...
Glaukos’ intraocular implant has performed comparably to topical timolol in the 24-month interim analysis of glaucoma patients enrolled in a phase 2b trial. The study is part of Glaukos’ preparations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results